A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis
- PMID: 3293973
- DOI: 10.2165/00003495-198800352-00036
A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis
Abstract
In an open prospective study performed in 2 neonatal units, infants with suspected neonatal sepsis (SNS) of unknown microbial cause were randomly allocated to receive treatment with either cefotaxime (CTX) or netilmicin plus penicillin (N + P). 236 patients were entered into the trial, of whom 222 were evaluable. The number of 'definitely' and 'probably' infected babies was similar in both groups. There was no difference in clinical outcome between patients in the 2 treatment groups and no side effects were recorded for either of the antibiotic regimens. Antibiotic sensitivity testing of bacterial isolates from peripheral sites showed almost universal sensitivity of potential pathogens to both antibiotic regimens at the start of treatment in all infants. Thereafter, organisms resistant to CTX were isolated from patients in both treatment groups, possibly reflecting the antibiotic sensitivity profile of the colonising bacteria in both neonatal units. The results of this study indicate that either CTX or N + P are suitable, in our units, for the 'blind' treatment of early SNS. In units where listerial infections are prevalent, specific cover should be added to CTX. For SNS developing after admission, the choice of antibiotics will depend upon the background antibiotic sensitivity profile of the colonising bacteria.
Similar articles
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
-
Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy.Acta Med Scand. 1983;213(5):345-9. doi: 10.1111/j.0954-6820.1983.tb03749.x. Acta Med Scand. 1983. PMID: 6308965 Clinical Trial.
-
A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis.Scand J Infect Dis. 1987;19(3):331-7. doi: 10.3109/00365548709018479. Scand J Infect Dis. 1987. PMID: 3616496 Clinical Trial.
-
The use of cefotaxime for treating suspected neonatal sepsis: 2 years' experience.J Hosp Infect. 1986 Jul;8(1):57-63. doi: 10.1016/0195-6701(86)90105-2. J Hosp Infect. 1986. PMID: 2875103
-
A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.J Chemother. 1989 Jul;1(4 Suppl):652-4. J Chemother. 1989. PMID: 16312576 No abstract available.
Cited by
-
Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.Clin Pharmacokinet. 1992 Apr;22(4):284-97. doi: 10.2165/00003088-199222040-00004. Clin Pharmacokinet. 1992. PMID: 1606788 Review.
-
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.Antimicrob Agents Chemother. 2007 Jun;51(6):1995-2000. doi: 10.1128/AAC.01506-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371819 Free PMC article.
-
Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials.Pediatr Res. 2022 Mar;91(4):735-742. doi: 10.1038/s41390-021-01883-y. Epub 2022 Jan 7. Pediatr Res. 2022. PMID: 34997225 Free PMC article.
-
Antibiotic regimens for suspected early neonatal sepsis.Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004495. doi: 10.1002/14651858.CD004495.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495114 Free PMC article.
-
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003. Drugs. 1989. PMID: 2689137 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical